IRADIMED CORPORATION — Income Charts
12 quarters of history · ending 2026-03-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+12.6% +$2M
$22M
Cost of Revenue↑+10.6% +$497K
$5M
Gross Profit↑+13.3% +$2M
$17M
R&D↑+53.2% +$332K
$956K
D&A↑+134.5% +$261K
$455K
Operating Income↑+33.2% +$2M
$7M
EBITDA↑+36.7% +$2M
$8M
Other Income/Expense↑+3.7% +$19K
$532K
Pretax Income↑+30.7% +$2M
$8M
Tax Provision↑+55.1% +$693K
$2M
Net Income↑+24.1% +$1M
$6M
Gross Margin↑+0.4pts
76.5%
Operating Margin↑+5.1pts
32.9%
Net Margin↑+2.4pts
26.5%
Effective Tax Rate↑+4.0pts
25.1%
Deferred Tax Assets↓-91.4% -$2M
$231K
Deferred Tax Liabilities
—
ETR (Continuing Operations)↑+0.0pts
20.7%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↑+0.0pts
3.5%
ETR Foreign Differential (pp)
—
Operating Lease Cost↓-97.2% -$328K
$9K
Revenue YoY Variation↑+1.8pts
12.6%
Income YoY Variation↑+18.8pts
33.2%
Revenue QoQ Variation↓-3.8pts
-3.1%
Income QoQ Variation↑+8.4pts
2.0%